应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
07666 剂泰科技-P
未开盘 09-09 16:08:04
18.370
+0.800
+4.55%
最高
20.540
最低
17.330
成交量
2,187万
今开
17.670
昨收
17.570
日振幅
18.27%
总市值
217.32亿
流通市值
198.95亿
总股本
11.83亿
成交额
4.08亿
换手率
2.02%
流通股本
10.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
港股异动 | 剂泰科技-P(07666.HK)午后涨超20% 入通两日累涨逾三成 全球AI+mRNA疫苗赛道提速
智通财经 · 09-08 14:01
港股异动 | 剂泰科技-P(07666.HK)午后涨超20% 入通两日累涨逾三成 全球AI+mRNA疫苗赛道提速
港股异动|生物技术板块午后拉升,剂泰科技涨近13%,百奥赛图涨超8%
老虎快讯 · 09-08 13:34
港股异动|生物技术板块午后拉升,剂泰科技涨近13%,百奥赛图涨超8%
港股生物医药股午后走强,剂泰科技-P涨近15%,百奥赛图-B、金斯瑞生物科技涨近10%
老虎资讯综合 · 09-08 13:33
港股生物医药股午后走强,剂泰科技-P涨近15%,百奥赛图-B、金斯瑞生物科技涨近10%
港股AI医疗概念股表现活跃,剂泰科技-P涨超9%,英矽智能涨超7%
老虎资讯综合 · 09-08 10:17
港股AI医疗概念股表现活跃,剂泰科技-P涨超9%,英矽智能涨超7%
港股异动 | 剂泰科技-P(07666)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位
智通财经 · 09-08 10:03
港股异动 | 剂泰科技-P(07666)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位
港股异动 | 剂泰科技-P(07666.HK)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位
智通财经 · 09-08 10:03
港股异动 | 剂泰科技-P(07666.HK)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位
剂泰科技-P盘中涨超16% 今日起正式调入港股通标的证券名单
新浪港股 · 09-07 10:13
剂泰科技-P盘中涨超16% 今日起正式调入港股通标的证券名单
港股异动丨“入通”今日生效,剂泰科技-P涨超16%,创逾三个月新高
格隆汇 · 09-07 09:56
港股异动丨“入通”今日生效,剂泰科技-P涨超16%,创逾三个月新高
港股异动 | 剂泰科技-P(07666)早盘涨超15% 领涨港股AI制药板块 AI4S商业化加速落地
智通财经 · 09-07 09:43
港股异动 | 剂泰科技-P(07666)早盘涨超15% 领涨港股AI制药板块 AI4S商业化加速落地
剂泰科技-P(07666)正式纳入港股通 打开内地投资者参与通道
智通财经 · 09-04
剂泰科技-P(07666)正式纳入港股通 打开内地投资者参与通道
剂泰科技-P盘中涨超8% 上半年营收超去年全年47%
新浪港股 · 09-04
剂泰科技-P盘中涨超8% 上半年营收超去年全年47%
港股异动 | 剂泰科技-P(07666.HK)涨超8% 上半年营收超去年全年47% AI4S从技术验证迈入价值兑现
智通财经 · 09-04
港股异动 | 剂泰科技-P(07666.HK)涨超8% 上半年营收超去年全年47% AI4S从技术验证迈入价值兑现
剂泰科技-P8月股份变动月报:股本结构保持稳定
公告速递 · 09-03
剂泰科技-P8月股份变动月报:股本结构保持稳定
港股异动 | 剂泰科技-P(07666.HK)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现
智通财经 · 08-26
港股异动 | 剂泰科技-P(07666.HK)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现
港股异动 | 剂泰科技-P(07666)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现
智通财经 · 08-26
港股异动 | 剂泰科技-P(07666)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现
从Moderna到剂泰科技,AI Biological迈入价值兑现新阶段
格隆汇 · 08-26
从Moderna到剂泰科技,AI Biological迈入价值兑现新阶段
剂泰科技-P(07666)2026中报:半年营收超去年全年47%,跨越式增长领跑AI4S生命科学落地
智通财经 · 08-26
剂泰科技-P(07666)2026中报:半年营收超去年全年47%,跨越式增长领跑AI4S生命科学落地
剂泰科技-P(07666)发布中期业绩,收入1.54亿元 同比增加13399%
智通财经 · 08-25
剂泰科技-P(07666)发布中期业绩,收入1.54亿元 同比增加13399%
剂泰科技-P(07666)上半年营收1.54亿元 同比增逾133倍
公告速递 · 08-25
剂泰科技-P(07666)上半年营收1.54亿元 同比增逾133倍
剂泰科技-P:2026年上半年客户合同收入同比飙升13,399%,达人民币1.543亿元
美股速递 · 08-25
剂泰科技-P:2026年上半年客户合同收入同比飙升13,399%,达人民币1.543亿元
暂无数据
公司概况
公司名称:
剂泰科技-P
所属市场:
SEHK
上市日期:
--
主营业务:
剂泰科技(北京)股份有限公司是一家主要从事人工智能(AI)纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础,涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案,包括AiTEM、AiLNP及AiRNA平台,用以模拟、预测及阐释纳米级别的相互作用关系,从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。
发行价格:
--
{"stockData":{"symbol":"07666","market":"HK","secType":"STK","nameCN":"剂泰科技-P","latestPrice":18.37,"timestamp":1788941284833,"preClose":17.57,"halted":0,"volume":21868722,"delay":0,"changeRate":0.045532157085941986,"floatShares":1083000000,"shares":1183000000,"eps":-0.544689186577055,"marketStatus":"未开盘","change":0.8,"latestTime":"09-09 16:08:04","open":17.67,"high":20.54,"low":17.33,"amount":408417800,"amplitude":0.182698,"askPrice":18.4,"askSize":7500,"bidPrice":18.3,"bidSize":5500,"shortable":0,"etf":0,"ttmEps":-0.40227979892246285,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789003800000},"marketStatusCode":0,"adr":0,"listingDate":1778601600000,"exchange":"SEHK","adjPreClose":17.57,"openAndCloseTimeList":[[1788917400000,1788926400000],[1788930000000,1788940800000]],"volumeRatio":1.7277392204222084,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/07666/tweets","defaultTab":"tweets","newsList":[{"id":"2665347323","title":"港股异动 | 剂泰科技-P(07666.HK)午后涨超20% 入通两日累涨逾三成 全球AI+mRNA疫苗赛道提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2665347323","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665347323?lang=zh_cn&edition=full","pubTime":"2026-09-08 14:01","pubTimestamp":1788847313,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136255696","title":"港股异动|生物技术板块午后拉升,剂泰科技涨近13%,百奥赛图涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136255696","media":"老虎快讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136255696?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:34","pubTimestamp":1788845673,"startTime":"0","endTime":"0","summary":"港股生物技术板块午后拉升,剂泰科技涨近13%,百奥赛图涨超8%,云顶新耀、基石药业涨超4%。","market":"uk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02315","07666","01952"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113703587","title":"港股生物医药股午后走强,剂泰科技-P涨近15%,百奥赛图-B、金斯瑞生物科技涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1113703587","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113703587?lang=zh_cn&edition=full","pubTime":"2026-09-08 13:33","pubTimestamp":1788845625,"startTime":"0","endTime":"0","summary":"9月8日,港股$生物(000504)$医药股午后走强,$剂泰科技-P(07666)$涨近15%,$百奥赛图-B(02315)$、$金斯瑞生物科技(01548)$涨近10%,$泰格医药(03347)$、$康希诺生物(06185)$、$云顶新耀(01952)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1191","BK1515","161726","BK1141","BK1583","BK0216","BK1161","KCAI","07666","HK0000306685.HKD","HK0000320223.HKD","BK1574","399441","HK0000306701.USD","BK4581","HK0000320264.USD","01952","BK4588","BK4585","XBI","03347","688796","06185","BK1576","VXUS","02315","01548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148739690","title":"港股AI医疗概念股表现活跃,剂泰科技-P涨超9%,英矽智能涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148739690","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148739690?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:17","pubTimestamp":1788833835,"startTime":"0","endTime":"0","summary":"9月8日,港股AI医疗概念股表现活跃,$剂泰科技-P(07666)$涨超9%,$英矽智能(03696)$涨超7%,$金斯瑞生物科技(01548)$涨超6%,$云知声(09678)$涨超4%,$医渡科技(02158)$、$晶泰控股(02228)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","ARTY","BK1161","VTHR","HK0000306701.USD","BK1518","BK1576","BK1583","03696","BK1189","HK0000320223.HKD","02228","VXUS","BK1617","BK1109","AIPO","01548","HK0000306685.HKD","KCAI","QTOC","BK4588","HK0000320264.USD","159891","CHAT","02158","07666","AGIX","BK4585","5RE.SI","09678"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665467933","title":"港股异动 | 剂泰科技-P(07666)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2665467933","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665467933?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:03","pubTimestamp":1788832998,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,剂泰科技-P早盘涨超7%。截至发稿,涨5.65%,报16.28港元,成交额7068.61万港元。消息面上,剂泰科技与绿叶制药在北京正式签署长期战略合作协议,剂泰科技成为绿叶制药在AI药物递送领域的首家战略合作单位。值得注意的是,上交所发布通知,剂泰科技-P正式调入港股通标的证券名单,该调整已于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖剂泰科技,正式解锁南向资金。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1493156.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1191","KCAI","VXUS","CHAT","BK4588","BK1606","QTOC","AIPO","02186","VTHR","AGIX","BK4585","07666","ARTY","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665467923","title":"港股异动 | 剂泰科技-P(07666.HK)早盘涨超7% 剂泰携手绿叶制药 成为其首家AI药物递送战略合作单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2665467923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665467923?lang=zh_cn&edition=full","pubTime":"2026-09-08 10:03","pubTimestamp":1788832998,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK1583","02186","BK1161","BK1606","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839538","title":"剂泰科技-P盘中涨超16% 今日起正式调入港股通标的证券名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839538","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665839538?lang=zh_cn&edition=full","pubTime":"2026-09-07 10:13","pubTimestamp":1788747180,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P早盘一度涨超16%,领涨AI制药概念股。截至发稿,股价上涨11.43%,报15.40港元,成交额1.554亿港元。上交所9月4日盘后发布通知,剂泰科技-P正式调入港股通标的证券名单,该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖剂泰科技,正式解锁南向资金。值得注意的是,上半年,剂泰科技NanoForge商业化成果进入集中释放期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-07/doc-iniqyeuh5782988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666","161027","FLHK","BK1161"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2665393440","title":"港股异动丨“入通”今日生效,剂泰科技-P涨超16%,创逾三个月新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2665393440","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665393440?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:56","pubTimestamp":1788746219,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665539313","title":"港股异动 | 剂泰科技-P(07666)早盘涨超15% 领涨港股AI制药板块 AI4S商业化加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2665539313","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665539313?lang=zh_cn&edition=full","pubTime":"2026-09-07 09:43","pubTimestamp":1788745407,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,剂泰科技-P早盘涨超15%,领涨AI制药概念股。截至发稿,涨12.81%,报15.59港元,成交额1.1亿港元。消息面上,上交所9月4日盘后发布通知,剂泰科技-P正式调入港股通标的证券名单,该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖剂泰科技,正式解锁南向资金。值得注意的是,上半年,剂泰科技NanoForge商业化成果进入集中释放期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AIPO","AGIX","BK1161","BK4588","ARTY","BK1574","BK1191","VTHR","CHAT","QTOC","KCAI","07666","VXUS","01477","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664586334","title":"剂泰科技-P(07666)正式纳入港股通 打开内地投资者参与通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2664586334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664586334?lang=zh_cn&edition=full","pubTime":"2026-09-04 20:33","pubTimestamp":1788525201,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,上交所9月4日盘后发布通知,根据《上海证券交易所沪港通业务实施办法》有关规定,剂泰科技-P正式调入港股通标的证券名单,该调整将于9月7日(周一)起生效。这意味着内地投资者自此可通过沪深港通直接买卖剂泰科技,正式解锁南向资金。今年上半年,剂泰科技实现营业收入1.54亿元,同比大幅增长13339%,超过去年全年收入47%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07666","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386985","title":"剂泰科技-P盘中涨超8% 上半年营收超去年全年47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386985","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664386985?lang=zh_cn&edition=full","pubTime":"2026-09-04 11:50","pubTimestamp":1788493800,"startTime":"0","endTime":"0","summary":"模拟交易客户端剂泰科技-P盘中涨超8%,截至发稿,股价上涨5.32%,现报13.86港元,成交额2743.45万港元。今年上半年,剂泰科技实现营业收入1.54亿元,同比大幅增长13339%,超过去年全年收入47%;经调整净亏损则大幅收窄56.4%至5110万元。今年6月30日,剂泰科技宣布与全球顶级健康投资与创新平台Deerfield支持成立的Boulevard Bio达成了一项总价最高达到16亿美元的全球独家授权协议,由此刷新了中国临床前TCE单笔授权金额的新纪录。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-09-04/doc-iniqrpqw4160984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664238307","title":"港股异动 | 剂泰科技-P(07666.HK)涨超8% 上半年营收超去年全年47% AI4S从技术验证迈入价值兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2664238307","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664238307?lang=zh_cn&edition=full","pubTime":"2026-09-04 10:32","pubTimestamp":1788489143,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195433135","title":"剂泰科技-P8月股份变动月报:股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1195433135","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195433135?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:37","pubTimestamp":1788424657,"startTime":"0","endTime":"0","summary":"2026年9月3日,剂泰科技-P披露了截至2026年8月31日的证券变动月报表。报告显示,截至本月末,公司股本结构保持稳定,未出现额外发行、购回或注销股份的情况。根据公告,公司法定注册股本总额约为人民币118,269,785元。其中,境内未上市股份(普通股)数量为99,587,739股,面值人民币0.1元,总额为人民币9,958,773.9元;H股数量为1,083,110,111股,面值人民币0.1元,总额为人民币108,311,011.1元。两类股份均未在本报告期内发生增加或减少。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769815","title":"港股异动 | 剂泰科技-P(07666.HK)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769815","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662769815?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:48","pubTimestamp":1787708924,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769813","title":"港股异动 | 剂泰科技-P(07666)绩后涨超8% 半年营收超去年全年47% 公司商业化里程碑加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769813","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662769813?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:48","pubTimestamp":1787708924,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,剂泰科技-P绩后涨超8%,截至发稿,涨7.97%,报14.9港元,成交额1682.1万港元。消息面上,8月25日,剂泰科技披露2026年中期业绩。报告期内,公司营业收入实现1.54亿元,同比大幅增长13339%,超过去年全年收入47%。2026上半年,NanoForge的平台能力得到国际专业投资机构和头部跨国药企的实质认可,连续落地商业里程碑,再次验证了NanoForge持续产出具有全球价值创新资产的实力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485744.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","07666","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662765465","title":"从Moderna到剂泰科技,AI Biological迈入价值兑现新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2662765465","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662765465?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:00","pubTimestamp":1787706055,"startTime":"0","endTime":"0","summary":"平台正在工作,资产正在产出,产业正在买单,战略正在从愿景走向现实。","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/110.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6304408","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["ARTY","VTHR","AGIX","AIPO","07666","QTOC","CHAT","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662961765","title":"剂泰科技-P(07666)2026中报:半年营收超去年全年47%,跨越式增长领跑AI4S生命科学落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2662961765","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662961765?lang=zh_cn&edition=full","pubTime":"2026-08-26 08:50","pubTimestamp":1787705444,"startTime":"0","endTime":"0","summary":"在全球生物制药从“靶点发现”迈向“精准递送”的范式转移中,剂泰科技-P依托创新自研的Biological AI关键基础设施NanoForge平台,公司深耕AI for Science、领跑Biological AI赛道的核心创新价值正不断被深入挖掘。智通财经APP了解到,8月25日,剂泰科技披露了2026年中期业绩。报告期内,公司营业收入实现1.54亿元,同比大幅增长13339%,超过去年全年收入47%。超10条管线梯次布局,三大维度能力跃迁提升在研发端,剂泰科技报告期内公司整体研发支出达1.72亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"剂泰科技-P(07666)2026中报:半年营收超去年全年47%,跨越式增长领跑AI4S生命科学落地","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662758738","title":"剂泰科技-P(07666)发布中期业绩,收入1.54亿元 同比增加13399%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662758738","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662758738?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:54","pubTimestamp":1787651673,"startTime":"0","endTime":"0","summary":"智通财经APP讯,剂泰科技-P 发布截至2026年6月30日止6个月中期业绩,该集团取得来自客户合约的收入人民币1.54亿元,同比增加13399%;经调整亏损净额人民币5109.9万元,同比减少56.4%;每股亏损人民币0.17元。报告期内,本集团持续推进以NanoForge为核心的技术平台迭代及研发成果转化。与此同时,NanoForge平台OpenCGT项目潜在交易总额已超过人民币60亿元,并新增多项针对肝靶向及肺靶向递送系统的研究合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"剂泰科技-P(07666)发布中期业绩,收入1.54亿元 同比增加13399%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","07666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106492506","title":"剂泰科技-P(07666)上半年营收1.54亿元 同比增逾133倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1106492506","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106492506?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:52","pubTimestamp":1787651529,"startTime":"0","endTime":"0","summary":"2026年8月25日,剂泰科技-P公布截至2026年6月30日止六个月未经审核业绩。上半年公司来自客户合约的收入为1.54亿元,同比大增13,399%;同期研发开支1.72亿元,同比增加48.1%。期内公司拥有人应占亏损1.53亿元,同比收窄20.0%;经调整亏损净额为5,109.9万元,同比减少56.4%。业务方面,公司披露,基于NanoForge平台自主研发的三特异性TCE项目MTS-128已完成全球独家授权,剂泰科技已收到首付款2,000万美元,并有资格获得最高16亿美元的开发、注册及商业化里程碑付款以及分级提成。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1112503843","title":"剂泰科技-P:2026年上半年客户合同收入同比飙升13,399%,达人民币1.543亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112503843","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112503843?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:49","pubTimestamp":1787651380,"startTime":"0","endTime":"0","summary":"剂泰科技-P披露最新财务数据——截至2026年6月30日的六个月内,公司与客户签订的合同所贡献的收入实现了爆发式增长,同比增幅高达13,399%,总额攀升至人民币1.543亿元。从近乎可以忽略的基数到如今逾亿级的收入规模,剂泰科技在短短一年间完成了令人瞩目的跨越。数据背后,是剂泰科技从研发积累向成果转化迈进的鲜明信号。随着合同履约能力的持续释放,公司下一阶段的业绩表现无疑将成为市场关注的焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07666","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.metistechbio.com","stockEarnings":[{"period":"1week","weight":0.4935},{"period":"1month","weight":0.5308},{"period":"3month","weight":0.4307},{"period":"6month","weight":0.7495},{"period":"ytd","weight":0.7495}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":-0.0255},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.0075},{"period":"1year","weight":-0.0256},{"period":"ytd","weight":-0.0139}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"剂泰科技(北京)股份有限公司是一家主要从事人工智能(AI)纳米材料创新的中国公司。NanoForge是该公司的人工智能驱动纳米科技创新体系的基础,涵盖脂质库、人工智能基础模型、METiS AI智能体、量子化学与分子动力学模拟及人工智能驱动的筛选平台。该公司开发了三大专业的解决方案,包括AiTEM、AiLNP及AiRNA平台,用以模拟、预测及阐释纳米级别的相互作用关系,从而实现对先进纳米材料及其相关有效载荷的合理设计、优化及验证。","exchange":"SEHK","name":"剂泰科技-P","nameEN":"METIS TECHBIO-P"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"剂泰科技-P,07666,剂泰科技-P股票,剂泰科技-P股票老虎,剂泰科技-P股票老虎国际,剂泰科技-P行情,剂泰科技-P股票行情,剂泰科技-P股价,剂泰科技-P股市,剂泰科技-P股票价格,剂泰科技-P股票交易,剂泰科技-P股票购买,剂泰科技-P股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"剂泰科技-P(07666)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供剂泰科技-P(07666)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}